Evaluation of intravitreal topotecan dose levels, toxicity and efficacy for retinoblastoma vitreous seeds: a preclinical and clinical study

MLA

Janene Pierce, et al. “Evaluation of Intravitreal Topotecan Dose Levels, Toxicity and Efficacy for Retinoblastoma Vitreous Seeds: A Preclinical and Clinical Study.” British Journal of Ophthalmology, vol. 106, May 2021, pp. 288–96. EBSCOhost, https://doi.org/10.1136/bjophthalmol-2020-318529.

APA

Janene Pierce, Kelli L. Boyd, Debra L. Friedman, Ann Richmond, Jessica V. Kaczmarek, Sheau-Chiann Chen, Craig W. Lindsley, Carley M. Bogan, Jennifer B Nadelmann, Jasmine H. Francis, Terry Hsieh, Marion W. Calcutt, David H. Abramson, Albert Liao, Thomas M. Bridges, & Anthony B. Daniels. (2021). Evaluation of intravitreal topotecan dose levels, toxicity and efficacy for retinoblastoma vitreous seeds: a preclinical and clinical study. British Journal of Ophthalmology, 106, 288–296. https://doi.org/10.1136/bjophthalmol-2020-318529

Chicago

Janene Pierce, Kelli L. Boyd, Debra L. Friedman, Ann Richmond, Jessica V. Kaczmarek, Sheau-Chiann Chen, Craig W. Lindsley, et al. 2021. “Evaluation of Intravitreal Topotecan Dose Levels, Toxicity and Efficacy for Retinoblastoma Vitreous Seeds: A Preclinical and Clinical Study.” British Journal of Ophthalmology 106 (May): 288–96. doi:10.1136/bjophthalmol-2020-318529.